Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb

This article was originally published in The Tan Sheet

Executive Summary

Exec VP and Chief Financial Officer Michael Autera will assume responsibility for the Mead Johnson nutritionals business as well as BMS' medical device units Convatec, Zimmer and Linvatec, effective Jan. 1. Autera will remain CFO until a replacement is named. In addition, Senior VP William Flatley "will assume responsibility for business strategy, the company's productivity enhancement initiatives and coordination of the restructuring effort of the corporate staff organization," BMS said. Flatley will continue to be responsible for corporate hospital accounts. Both Autera and Flatley will report to President Charles Heimbold, who becomes CEO on Jan. 1.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel